Trial · NCT07052682
Results by group11
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 11 of 11
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Ontamalimab | 6 | Participants | ||
| Number of Participants With Clinically Significant Abnormalities in Clinical Laboratory Values | Ontamalimab | Serum Chemistry | 0 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in Clinical Laboratory Values | Ontamalimab | Hematology | 0 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in Clinical Laboratory Values | Ontamalimab | Urinalysis | 0 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in Clinical Laboratory Values | Ontamalimab | Coagulation | 0 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in 12-lead Electrocardiogram (ECGs) Findings | Ontamalimab | 0 | Participants | ||
| Number of Participants With Clinically Significant Abnormalities in Vital Signs | Ontamalimab | 0 | Participants | ||
| Number of Participants With Clinically Significant Abnormalities in Body Weight | Ontamalimab | 0 | Participants | ||
| Percent Change From Baseline in Pro-Collagen Type III (Pro-C3) Through Week 24 | Ontamalimab | -11.88 | 95% Confidence Interval -26.13 to 2.37 | percent change | |
| Percent Change From Baseline in Enhanced Liver Fibrosis (ELF) Through Week 24 | Ontamalimab | -0.13 | 95% Confidence Interval -3.61 to 3.35 | percent change | |
| Change From Baseline in Liver Iron-corrected T1 Mapping by Magnetic Resonance Imaging (cT1 MRI) at Week 24 | Ontamalimab | -32.0 | Standard Deviation 39.77 | millisecond (ms) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07052682/results